Reviving the Pharmaceutical Industry: Overcoming Vaccine Defeat
A new command center is setting out to promote the development of domestic vaccines through creation of a more supportive research and funding environment.
Stay updated with breaking news from Junichi Koga. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new command center is setting out to promote the development of domestic vaccines through creation of a more supportive research and funding environment.
Daiichi Sankyo, Clover Biopharmaceuticals and Insilico Medicine made our news this week. (Google) Amid a big cancer push, Daiichi Sankyo lured Kite Pharma exec Ken Takeshita to lead its R&D work. China's Clover Biopharmaceuticals secured $230 million in an oversubscribed series C to help advance its COVID-19 vaccine program and expand manufacturing capabilities. In several firsts for artificial-intelligence-based drug discovery, Insilico Medicine discovered a novel target for idiopathic pulmonary fibrosis, designed a new molecule and validated it in preclinical models in 18 months. And more...